Table of Contents
ISRN Nephrology
Volume 2014 (2014), Article ID 376795, 7 pages
http://dx.doi.org/10.1155/2014/376795
Research Article

Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis

1Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig 44511, Egypt
2Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig 44511, Egypt
3Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig 44511, Egypt

Received 21 February 2014; Accepted 12 March 2014; Published 6 April 2014

Academic Editors: J. Almirall, F. Artunc, and C. G. Musso

Copyright © 2014 Anass Ahmed Qasem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. El Gaafary, C. Rekacewicz, A. G. Abdel-Rahman et al., “Surveillance of acute hepatitis C in Cairo, Egypt,” Journal of Medical Virology, vol. 76, no. 4, pp. 520–525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Garcia-Tsao, C. R. Parikh, and A. Viola, “Acute kidney injury in cirrhosis,” Hepatology, vol. 48, no. 6, pp. 2064–2077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. du Cheyron, B. Bouchet, J. Parienti, M. Ramakers, and P. Charbonneau, “The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis,” Intensive Care Medicine, vol. 31, no. 12, pp. 1693–1699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Iwakiri and R. J. Groszmann, “The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule,” Hepatology, vol. 43, pp. S121–S131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Cholongitas, V. Shusang, L. Marelli et al., “Review article: renal function assessment in cirrhosis—difficulties and alternative measurements,” Alimentary Pharmacology and Therapeutics, vol. 26, no. 7, pp. 969–978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Wong, M. K. Nadim, J. A. Kellum et al., “Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis,” Gut, vol. 60, no. 5, pp. 702–709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Salerno, A. Gerbes, P. Ginès, F. Wong, and V. Arroyo, “Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis,” Gut, vol. 56, no. 9, pp. 1310–1318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Bellomo, C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky, “Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group,” Critical Care, vol. 8, no. 4, pp. R204–R212, 2004. View at Google Scholar · View at Scopus
  9. R. L. Mehta and J. Bouchard, “Controversies in acute kidney injury: effects of fluid overload on outcome,” Contributions to Nephrology, vol. 174, pp. 200–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Ginès, P. Angeli, K. Lenz et al., “EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis,” Journal of Hepatology, vol. 53, no. 3, pp. 397–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Bachorzewska-Gajewska, J. Malyszko, E. Sitniewska, J. S. Malyszko, and S. Dobrzycki, “Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions,” American Journal of Nephrology, vol. 26, no. 3, pp. 287–292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Makris, N. Markou, E. Evodia et al., “Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients,” Clinical Chemistry and Laboratory Medicine, vol. 47, no. 1, pp. 79–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. L. Nickolas, M. J. O'Rourke, J. Yang et al., “Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury,” Annals of Internal Medicine, vol. 148, no. 11, pp. 810–819, 2008. View at Google Scholar · View at Scopus
  14. T. Jeong, S. Kim, W. Lee et al., “Neutrophil gelatinase-associated lipocalin as an early biomarker of acute kidney injury in liver transplantation,” Clinical Transplantation, vol. 26, pp. 775–781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. R. Parikh, A. Jani, V. Y. Melnikov, S. Faubel, and C. L. Edelstein, “Urinary interleukin-18 is a marker of human acute tubular necrosis,” American Journal of Kidney Diseases, vol. 43, no. 3, pp. 405–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. R. Parikh and P. Devarajan, “New biomarkers of acute kidney injury,” Critical Care Medicine, vol. 36, pp. S159–S165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. N. Pugh, I. M. Murray-Lyon, J. L. Dawson et al., “Transection of the esophagus in the bleeding esophageal varices,” British Journal of Surgery, vol. 60, pp. 648–652, 1973. View at Google Scholar
  18. R. Moreau and D. Lebrec, “Acute renal failure in patients with cirrhosis: perspectives in the age of MELD,” Hepatology, vol. 37, no. 2, pp. 233–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar · View at Scopus
  20. V. Arroyo, C. Terra, and P. Ginès, “Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome,” Journal of Hepatology, vol. 46, no. 5, pp. 935–946, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. S. Levey, J. Coresh, E. Balk et al., “National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” Annals of Internal Medicine, vol. 139, pp. 137–147, 2003. View at Google Scholar
  22. R. W. Schrier, “Diagnostic value of urinary sodium, chloride, urea, and flow,” Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1610–1613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. K. Mandal, M. Lansing, and A. Fahmy, “Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study,” American Journal of Kidney Diseases, vol. 2, no. 3, pp. 363–374, 1982. View at Google Scholar · View at Scopus
  24. W. G. Rector Jr., G. C. Kanel, J. Rakela, and T. B. Reynolds, “Tubular dysfunction in the deeply jaundiced patient with hepatorenal syndrome,” Hepatology, vol. 5, no. 2, pp. 321–326, 1985. View at Google Scholar · View at Scopus
  25. P. Angeli, R. Volpin, G. Gerunda et al., “Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide,” Hepatology, vol. 29, no. 6, pp. 1690–1697, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. M. L. Esson and R. W. Schrier, “Diagnosis and treatment of acute tubular necrosis,” Annals of Internal Medicine, vol. 137, no. 9, pp. 744–752, 2002. View at Google Scholar · View at Scopus
  27. A. Ochs, M. Rossle, K. Haag et al., “The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites,” The New England Journal of Medicine, vol. 332, no. 18, pp. 1192–1197, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Iwatsuki, M. M. Popovtzer, and J. L. Corman, “Recovery from “hepatorenal syndrome” after orthotopic liver transplantation,” The New England Journal of Medicine, vol. 289, no. 22, pp. 1155–1159, 1973. View at Google Scholar · View at Scopus
  29. C. Cassinello, E. Moreno, A. Gozalo, B. Ortuño, B. Cuenca, and J. A. Solís-Herruzo, “Effects of Orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis,” Digestive Diseases and Sciences, vol. 48, no. 1, pp. 179–186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. F. D. McDonald, L. A. Brennan, and J. G. Turcotte, “Severe hypertension and elevated plasma renin activity following transplantation of “hepatorenal donor” kidneys into anephric recipients,” The American Journal of Medicine, vol. 54, no. 1, pp. 39–43, 1973. View at Google Scholar · View at Scopus
  31. M. H. Koppel, J. W. Coburn, M. M. Mims, H. Goldstein, J. D. Boyle, and M. E. Rubini, “Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease,” The New England Journal of Medicine, vol. 280, no. 25, pp. 1367–1371, 1969. View at Google Scholar · View at Scopus
  32. G. C. Kanel and R. L. Peter, “Glomerular tubular reflex. A morphologic renal lesion associated with the hepatorenal syndrome,” Hepatology, vol. 4, no. 2, pp. 242–246, 1984. View at Google Scholar · View at Scopus
  33. N. K. Hollenberg, “Aldosterone in the development and progression of renal injury,” Kidney International, vol. 66, no. 1, pp. 1–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. E. D. Siew, T. A. Ikizler, T. Gebretsadik et al., “Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 8, pp. 1497–1505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Devarajan, “Biomarkers for the early detection of acute kidney injury,” Current Opinion in Pediatrics, vol. 23, no. 2, pp. 194–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. E. C. Verna, R. S. Brown, E. Farrand et al., “Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis,” Digestive Diseases and Sciences, vol. 57, pp. 2362–2370, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Papadakis and A. I. Arieff, “Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study,” The American Journal of Medicine, vol. 82, no. 5, pp. 945–952, 1987. View at Google Scholar · View at Scopus
  38. A. S. Levey, J. Coresh, T. Greene et al., “Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values,” Clinical Chemistry, vol. 53, no. 4, pp. 766–772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Gill, J. V. Natty Jr., and R. A. Fatica, “Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management,” Chest, vol. 128, no. 4, pp. 2847–2863, 2005. View at Publisher · View at Google Scholar · View at Scopus